Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03303391 · ClinicalTrials.gov registry record · NA
Using Intradialytic Blood Pressure Slopes to Guide Ultrafiltration
A NA study, sponsored by University of Texas Southwestern Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT03303391: Clinical Trial NA study, sponsored by University of Texas Southwestern Medical Center.
NCT03303391 is a NA study that was terminated before completion, run by University of Texas Southwestern Medical Center. The registered enrollment target is 14 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03303391, a NA study, was terminated before completion, sponsored by University of Texas Southwestern Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
This study is an open label randomized clinical trial that comparing intradialytic blood pressure slope-based ultrafiltration prescriptions to standard care in the chronic fluid management of maintenance hemodialysis patients. It also includes a cross sectional component evaluating the associations between intradialytic blood pressure slopes ascertained over 2 week periods with measurements of extracellular water/body weight obtained with multifrequency bioimpedance spectroscopy.
Primary Outcome
The change in mean systolic ambulatory blood pressure from study baseline to completion (4 months)
Interventions
- OTHER Intradialytic Blood Pressure Slope Based Ultrafiltration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2017-11-01 |
| Est. Completion | 2020-01-01 |
| Phase | NA |
Why NCT03303391 stopped before completion
NCT03303391 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Intradialytic Blood Pressure Slope Based Ultrafiltration is the first listed.
NCT03303391 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03303391 about?
NCT03303391 is a clinical study titled "Using Intradialytic Blood Pressure Slopes to Guide Ultrafiltration". This study is an open label randomized clinical trial that comparing intradialytic blood pressure slope-based ultrafiltration prescriptions to standard care in the chronic fluid management of maintenance hemodialysis patients. It also includes a cross sectional component evaluating the associations ...
What is the current status of trial NCT03303391?
This trial is currently terminated. It is a NA study. The enrollment target is 14 participants. The study started on 2017-11-01. Estimated completion is 2020-01-01.
What interventions are being tested in trial NCT03303391?
The interventions under investigation include: Intradialytic Blood Pressure Slope Based Ultrafiltration (OTHER).
Who is sponsoring clinical trial NCT03303391?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03303391's enrollment target sits among peer trials
14 1909th of 2000 higher than 90 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy